Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cancer ; 120(4): 521-9, 2014 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-24166051

RESUMEN

BACKGROUND: Several studies have suggested that low 25(OH) vitamin D3 levels may be prognostic in some malignancies, but no studies have evaluated their impact on treatment outcome in patients with acute myeloid leukemia (AML). METHODS: Vitamin D levels were evaluated in 97 consecutive, newly diagnosed, intensively treated patients with AML. MicroRNA expression profiles and single nucleotide polymorphisms (SNPs) in the 25(OH) vitamin D3 pathway genes were evaluated and correlated with 25(OH) vitamin D3 levels and treatment outcome. RESULTS: Thirty-four patients (35%) had normal 25(OH) vitamin D3 levels (32-100 ng/mL), 34 patients (35%) had insufficient levels (20-31.9 ng/mL), and 29 patients (30%) had deficient levels (<20 ng/mL). Insufficient/deficient 25(OH) vitamin D3 levels were associated with worse relapse-free survival (RFS) compared with normal vitamin D3 levels. In multivariate analyses, deficient 25(OH) vitamin D3 , smoking, European Leukemia Network genetic group, and white blood cell count retained their statistical significance for RFS. Several microRNAs and SNPs were associated with 25(OH) vitamin D3 levels, although none remained significant after multiple test corrections; one 25(OH) vitamin D3 receptor SNP, rs10783219, was associated with a lower complete remission rate (P = .0442) and with shorter RFS (P = .0058) and overall survival (P = .0011). CONCLUSIONS: It remains to be determined what role microRNA and SNP profiles play in contributing to low 25(OH) vitamin D3 level and/or outcome and whether supplementation will improve outcomes for patients with AML.


Asunto(s)
Calcifediol/sangre , Colecalciferol/sangre , Regulación Neoplásica de la Expresión Génica , Leucemia Mieloide Aguda/sangre , MicroARNs/genética , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/patología , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/sangre , Recurrencia Local de Neoplasia/patología , Polimorfismo de Nucleótido Simple/genética , Pronóstico , Receptores de Calcitriol/genética , Transcriptoma , Resultado del Tratamiento
2.
J Am Board Fam Pract ; 18(2): 132-9, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15798142

RESUMEN

Klinefelter syndrome is an underdiagnosed chromosomal disorder that has significant implications for health and for medical management. This report presents 5 adult male patients diagnosed with previously unsuspected Klinefelter syndrome as a result of cytogenetic testing for suspected hematologic malignancies. This case series highlights the importance of maintaining a comprehensive and holistic approach to medical care. The medical, genetic, and psychosocial implications of the Klinefelter diagnosis are discussed.


Asunto(s)
Síndrome de Klinefelter/diagnóstico , Biopsia con Aguja , Médula Ósea/patología , Análisis Citogenético/métodos , Diagnóstico Diferencial , Neoplasias Hematológicas/diagnóstico , Humanos , Cariotipificación/métodos , Síndrome de Klinefelter/genética , Síndrome de Klinefelter/terapia , Masculino , Oncología Médica/métodos , Persona de Mediana Edad , Atención Primaria de Salud/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA